Compound details
Alstophyllal
| Compound ID | CDAMM00506 |
|---|---|
| Common name | Alstophyllal | IUPAC name | 6-methoxy-3,16,20-trimethyl-15-oxa-3,20-diazapentacyclo[10.7.1.02,10.04,9.013,18]icosa-2(10),4(9),5,7,16-pentaene-17-carbaldehyde |
| Molecular formula | C22H26N2O3 |
| Retention time | 10.99 |
|---|---|
| Adduct | [M+Na]+ |
| Actual mz | 389.183 | Theoretical mz | 389.183 |
| Error | 1.59 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.0475 |
| Inchi key | OKOHMBRGHIAYBH-ZTHXDYBINA-N |
|---|---|
| Smiles | O=CC1=C(OCC2C1CC3C4=C(C=5C=CC(OC)=CC5N4C)CC2N3C)C |
| Superclass | Alkaloids and derivatives |
| Class | Macroline alkaloids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P34903 | GABRA3 | GABA A receptor alpha-3/beta-2/gamma-2 | T62292 | SwissTargetPrediction |
| P47869 | GABRA2 | GABA A receptor alpha-2/beta-2/gamma-2 | T51452 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P21917 | DRD4 | Dopamine D4 receptor | T24983 | SwissTargetPrediction |
| P21397 | MAOA | Monoamine oxidase A | T83875 | SwissTargetPrediction |
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P16083 | NQO2 | Quinone reductase 2 | T75498 | SwissTargetPrediction |
| P14416 | DRD2 | Dopamine D2 receptor | T67162 | SwissTargetPrediction |
| P13866 | SLC5A1 | Sodium/glucose cotransporter 1 | T54771 | SwissTargetPrediction |
| Q02083 | NAAA | N-acylsphingosine-amidohydrolase (by homology) | T78326 | SwissTargetPrediction |
| P28223 | HTR2A | Serotonin 2a (5-HT2a) receptor | T32060 | SwissTargetPrediction |
| P08913 | ADRA2A | Alpha-2a adrenergic receptor | T11448 | SwissTargetPrediction |
| P08908 | HTR1A | Serotonin 1a (5-HT1a) receptor | T78709 | SwissTargetPrediction |
| P50406 | HTR6 | Serotonin 6 (5-HT6) receptor | T16691 | SwissTargetPrediction |
| P14867 | GABRA1 | GABA-A receptor; alpha-1/beta-2/gamma-2 | T51487 | SwissTargetPrediction |
| P15538 | CYP11B1 | Cytochrome P450 11B1 | T84621 | SwissTargetPrediction |
| P19099 | CYP11B2 | Cytochrome P450 11B2 | T59056 | SwissTargetPrediction |
| P07384 | CAPN1 | Calpain 1 | T92517 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| O60885 | BRD4 | Bromodomain-containing protein 4 | T00407 | SwissTargetPrediction |
| P25440 | BRD2 | Bromodomain-containing protein 2 | T86597 | SwissTargetPrediction |
| O00519 | FAAH | Anandamide amidohydrolase | T11754 | SwissTargetPrediction |
| P08235 | NR3C2 | Mineralocorticoid receptor | T72168 | SwissTargetPrediction |
| P11511 | CYP19A1 | Cytochrome P450 19A1 | T13260 | SwissTargetPrediction |
| P51681 | CCR5 | C-C chemokine receptor type 5 | T09960 | SwissTargetPrediction |
| P07339 | CTSD | Cathepsin D | T67102 | SwissTargetPrediction |
| Q9H3N8 | HRH4 | Histamine H4 receptor | T26500 | SwissTargetPrediction |
| P28845 | HSD11B1 | 11-beta-hydroxysteroid dehydrogenase 1 | T65200 | SwissTargetPrediction |
| Q8TDU6 | GPBAR1 | G-protein coupled bile acid receptor 1 | T86273 | SwissTargetPrediction |
| Q13133 | NR1H3 | LXR-alpha | T52297 | SwissTargetPrediction |
| P35462 | DRD3 | Dopamine D3 receptor | T02551 | SwissTargetPrediction |
| P18825 | ADRA2C | Adrenergic receptor alpha-2 | T01777 | SwissTargetPrediction |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction |
| P35372 | OPRM1 | Mu opioid receptor | T47768 | SwissTargetPrediction |
| Q9H2K2 | TNKS2 | Tankyrase-2 | T38087 | SwissTargetPrediction |
| O95271 | TNKS | Tankyrase-1 | T83059 | SwissTargetPrediction |
| P00519 | ABL1 | Tyrosine-protein kinase ABL | T63505 | SwissTargetPrediction |
| P06276 | BCHE | Butyrylcholinesterase | T99799 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| P36888 | FLT3 | Tyrosine-protein kinase receptor FLT3 | T74312 | SwissTargetPrediction |
| P45452 | MMP13 | Matrix metalloproteinase 13 | T34296 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P49327 | FASN | Fatty acid synthase | T16514 | SwissTargetPrediction |
| P07711 | CTSL | Cathepsin L | T98691 | SwissTargetPrediction |
| P07858 | CTSB | Cathepsin (B and K) | T61746 | SwissTargetPrediction |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SwissTargetPrediction |
| P23946 | CMA1 | Chymase | T05114 | SwissTargetPrediction |
| P62942 | FKBP1A | FK506-binding protein 1A | T76059 | SwissTargetPrediction |
| Q08499 | PDE4D | Phosphodiesterase 4D | T02001 | SwissTargetPrediction |
| Q96S37 | SLC22A12 | Solute carrier family 22 member 12 | T86057 | SwissTargetPrediction |
| P49356 | FNTB | Farnesyl protein transferase | T13127 | SwissTargetPrediction |
| P80365 | HSD11B2 | 11-beta-hydroxysteroid dehydrogenase 2 | T43721 | SwissTargetPrediction |
| P13500 | CCL2 | C-C motif chemokine 2 | T89988 | SwissTargetPrediction |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction |
| P32246 | CCR1 | C-C chemokine receptor type 1 | T16016 | SwissTargetPrediction |
| Q15858 | SCN9A | Sodium channel protein type IX alpha subunit | T12119 | SwissTargetPrediction |
| Q14432 | PDE3A | Phosphodiesterase 3 | T88975 | SwissTargetPrediction |
| Q99572 | P2RX7 | P2X purinoceptor 7 | T63414 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| P25098 | GRK2 | G-protein coupled receptor kinase 2 | T62548 | SwissTargetPrediction |
| P34947 | GRK5 | G protein-coupled receptor kinase 5 | T69612 | SwissTargetPrediction |
| P24385 | CCND1 | Cyclin-dependent kinase 4/cyclin D1 | T12355 | SwissTargetPrediction |
| P18089 | ADRA2B | Alpha-2b adrenergic receptor | T41580 | SwissTargetPrediction |
| Q9UGL1 | KDM5B | Lysine-specific demethylase 5B | T56871 | SwissTargetPrediction |
| P31644 | GABRA5 | GABA receptor alpha-5 subunit | T26368 | SwissTargetPrediction |
| P07333 | CSF1R | Macrophage colony stimulating factor receptor | T20333 | SwissTargetPrediction |
| P49840 | GSK3A | Glycogen synthase kinase-3 alpha | T76910 | SwissTargetPrediction |
| P50750 | CDK9 | Cyclin-dependent kinase 9 | T44458 | SwissTargetPrediction |
| Q12908 | SLC10A2 | Ileal bile acid transporter | T24982 | SwissTargetPrediction |
| P34998 | CRHR1 | Corticotropin releasing factor receptor 1 (by homology) | T45262 | SwissTargetPrediction |
| P49336 | CDK8 | Cell division protein kinase 8 | T10822 | SwissTargetPrediction |
| Q00987 | MDM2 | p53-binding protein Mdm-2 | T00176 | SwissTargetPrediction |
| Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | T77537 | SwissTargetPrediction |
| Q9UNQ0 | ABCG2 | ATP-binding cassette sub-family G member 2 | T56556 | SwissTargetPrediction |
| O43614 | HCRTR2 | Orexin receptor 2 | T69485 | SwissTargetPrediction |
| O43613 | HCRTR1 | Orexin receptor 1 | T73482 | SwissTargetPrediction |
| Q02763 | TEK | Tyrosine-protein kinase TIE-2 | T92144 | SwissTargetPrediction |
| P22460 | KCNA5 | Voltage-gated potassium channel subunit Kv1.5 | T17569 | SwissTargetPrediction |
| P22001 | KCNA3 | Voltage-gated potassium channel subunit Kv1.3 | T76914 | SwissTargetPrediction |
| Q13370 | PDE3B | Phosphodiesterase 3B | T21357 | SwissTargetPrediction |
| Q13464 | ROCK1 | Rho-associated protein kinase 1 | T51282 | SwissTargetPrediction |
| P20248 | CCNA2 | CDK2/Cyclin A | T58470 | SwissTargetPrediction |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SwissTargetPrediction |
| Q9NRA0 | SPHK2 | Sphingosine kinase 2 | T31989 | SwissTargetPrediction |
| P55055 | NR1H2 | LXR-beta | T13714 | SwissTargetPrediction |
| P33316 | DUT | dUTP pyrophosphatase | T39054 | SwissTargetPrediction |
| Q99814 | EPAS1 | Endothelial PAS domain-containing protein 1 | T21123 | SwissTargetPrediction |
| P18507 | GABRG2 | GABA-A receptor; alpha-6/beta-3/gamma-2 | T08910 | SwissTargetPrediction |
| Q6DWJ6 | GPR139 | Probable G-protein coupled receptor 139 | T84439 | SwissTargetPrediction |
| P08311 | CTSG | Cathepsin G | T86385 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T62292 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P34903 | GABRA3 |
| T51452 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P47869 | GABRA2 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T24983 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21917 | DRD4 |
| T24983 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P21917 | DRD4 |
| T83875 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P21397 | MAOA |
| T83875 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21397 | MAOA |
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T75498 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P16083 | NQO2 |
| T67162 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P14416 | DRD2 |
| T67162 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P14416 | DRD2 |
| T67162 | DI0037 | Asthma | [ICD-11: CA23] | P14416 | DRD2 |
| T67162 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P14416 | DRD2 |
| T67162 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P14416 | DRD2 |
| T67162 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P14416 | DRD2 |
| T67162 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P14416 | DRD2 |
| T67162 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P14416 | DRD2 |
| T67162 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14416 | DRD2 |
| T67162 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P14416 | DRD2 |
| T67162 | DI0137 | Essential hypertension | [ICD-11: BA00] | P14416 | DRD2 |
| T67162 | DI0142 | Faecal incontinence | [ICD-11: ME07] | P14416 | DRD2 |
| T67162 | DI0156 | Gangrene | [ICD-11: MC85] | P14416 | DRD2 |
| T67162 | DI0166 | Glaucoma | [ICD-11: 9C61] | P14416 | DRD2 |
| T67162 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P14416 | DRD2 |
| T67162 | DI0185 | Hyperaemia | [ICD-11: 9A61-9B7Y] | P14416 | DRD2 |
| T67162 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P14416 | DRD2 |
| T67162 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P14416 | DRD2 |
| T67162 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | P14416 | DRD2 |
| T67162 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14416 | DRD2 |
| T67162 | DI0222 | Itching | [ICD-11: 1F28-1G07] | P14416 | DRD2 |
| T67162 | DI0264 | Migraine | [ICD-11: 8A80] | P14416 | DRD2 |
| T67162 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P14416 | DRD2 |
| T67162 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P14416 | DRD2 |
| T67162 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P14416 | DRD2 |
| T67162 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P14416 | DRD2 |
| T67162 | DI0340 | Postpartum haemorrhage | [ICD-11: JA43] | P14416 | DRD2 |
| T67162 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P14416 | DRD2 |
| T67162 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P14416 | DRD2 |
| T67162 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P14416 | DRD2 |
| T67162 | DI0396 | Substance abuse | [ICD-11: 6C40] | P14416 | DRD2 |
| T67162 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P14416 | DRD2 |
| T67162 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P14416 | DRD2 |
| T54771 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P13866 | SLC5A1 |
| T54771 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P13866 | SLC5A1 |
| T54771 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P13866 | SLC5A1 |
| T32060 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P28223 | HTR2A |
| T32060 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P28223 | HTR2A |
| T32060 | DI0073 | Cerebral ischaemia | [ICD-11: 8B1Z] | P28223 | HTR2A |
| T32060 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P28223 | HTR2A |
| T32060 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P28223 | HTR2A |
| T32060 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28223 | HTR2A |
| T32060 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P28223 | HTR2A |
| T11448 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P08913 | ADRA2A |
| T11448 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P08913 | ADRA2A |
| T11448 | DI0396 | Substance abuse | [ICD-11: 6C40] | P08913 | ADRA2A |
| T78709 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P08908 | HTR1A |
| T78709 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P08908 | HTR1A |
| T78709 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08908 | HTR1A |
| T78709 | DI0264 | Migraine | [ICD-11: 8A80] | P08908 | HTR1A |
| T78709 | DI0270 | Mood disorder | [ICD-11: 6A60-6E23] | P08908 | HTR1A |
| T16691 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P50406 | HTR6 |
| T16691 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P50406 | HTR6 |
| T51487 | DI0014 | Acute respiratory distress syndrome | [ICD-11: CB00] | P14867 | GABRA1 |
| T51487 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P14867 | GABRA1 |
| T51487 | DI0082 | Chronic insomnia | [ICD-11: 7A00] | P14867 | GABRA1 |
| T51487 | DI0087 | Chronic pain | [ICD-11: MG30] | P14867 | GABRA1 |
| T51487 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P14867 | GABRA1 |
| T51487 | DI0112 | Cystitis | [ICD-11: GC00] | P14867 | GABRA1 |
| T51487 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P14867 | GABRA1 |
| T51487 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P14867 | GABRA1 |
| T51487 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P14867 | GABRA1 |
| T51487 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P14867 | GABRA1 |
| T51487 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P14867 | GABRA1 |
| T51487 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P14867 | GABRA1 |
| T51487 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P14867 | GABRA1 |
| T84621 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P15538 | CYP11B1 |
| T84621 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P15538 | CYP11B1 |
| T59056 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P19099 | CYP11B2 |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T86597 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P25440 | BRD2 |
| T11754 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | O00519 | FAAH |
| T72168 | DI0018 | Adrenocortical insufficiency | [ICD-11: 5A74] | P08235 | NR3C2 |
| T72168 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P08235 | NR3C2 |
| T72168 | DI0100 | Contraceptive management | [ICD-11: QA21] | P08235 | NR3C2 |
| T72168 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P08235 | NR3C2 |
| T72168 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08235 | NR3C2 |
| T72168 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P08235 | NR3C2 |
| T13260 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11511 | CYP19A1 |
| T13260 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P11511 | CYP19A1 |
| T09960 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P51681 | CCR5 |
| T67102 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07339 | CTSD |
| T26500 | DI0037 | Asthma | [ICD-11: CA23] | Q9H3N8 | HRH4 |
| T26500 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9H3N8 | HRH4 |
| T26500 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9H3N8 | HRH4 |
| T26500 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9H3N8 | HRH4 |
| T26500 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q9H3N8 | HRH4 |
| T65200 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P28845 | HSD11B1 |
| T65200 | DI0239 | Lupus erythematosus | [ICD-11: 4A40] | P28845 | HSD11B1 |
| T65200 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P28845 | HSD11B1 |
| T86273 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | Q8TDU6 | GPBAR1 |
| T52297 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | Q13133 | NR1H3 |
| T02551 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P35462 | DRD3 |
| T02551 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35462 | DRD3 |
| T01777 | DI0166 | Glaucoma | [ICD-11: 9C61] | P18825 | ADRA2C |
| T01777 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P18825 | ADRA2C |
| T01777 | DI0196 | Hypotension | [ICD-11: BA20-BA21] | P18825 | ADRA2C |
| T01777 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P18825 | ADRA2C |
| T01777 | DI0310 | Ocular disease | [ICD-11: N.A.] | P18825 | ADRA2C |
| T01777 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18825 | ADRA2C |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T47768 | DI0013 | Acute pain | [ICD-11: MG31] | P35372 | OPRM1 |
| T47768 | DI0059 | Bowel habit change | [ICD-11: ME05] | P35372 | OPRM1 |
| T47768 | DI0087 | Chronic pain | [ICD-11: MG30] | P35372 | OPRM1 |
| T47768 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P35372 | OPRM1 |
| T47768 | DI0105 | Cough | [ICD-11: MD12] | P35372 | OPRM1 |
| T47768 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35372 | OPRM1 |
| T47768 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P35372 | OPRM1 |
| T47768 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P35372 | OPRM1 |
| T47768 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P35372 | OPRM1 |
| T47768 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P35372 | OPRM1 |
| T47768 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35372 | OPRM1 |
| T47768 | DI0349 | Pruritus | [ICD-11: EC90] | P35372 | OPRM1 |
| T47768 | DI0374 | Sensation disturbance | [ICD-11: MB40] | P35372 | OPRM1 |
| T38087 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | Q9H2K2 | TNKS2 |
| T83059 | DI0060 | Brain cancer | [ICD-11: 2A00] | O95271 | TNKS |
| T83059 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O95271 | TNKS |
| T83059 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O95271 | TNKS |
| T83059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O95271 | TNKS |
| T63505 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00519 | ABL1 |
| T63505 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00519 | ABL1 |
| T63505 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P00519 | ABL1 |
| T63505 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P00519 | ABL1 |
| T99799 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P06276 | BCHE |
| T99799 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P06276 | BCHE |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T74312 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P36888 | FLT3 |
| T74312 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P36888 | FLT3 |
| T74312 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P36888 | FLT3 |
| T74312 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P36888 | FLT3 |
| T74312 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P36888 | FLT3 |
| T74312 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P36888 | FLT3 |
| T74312 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P36888 | FLT3 |
| T74312 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P36888 | FLT3 |
| T34296 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45452 | MMP13 |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T16514 | DI0096 | concerning food/fluid intake symptom | [ICD-11: MG43] | P49327 | FASN |
| T98691 | DI0263 | Middle East Respiratory Syndrome | [ICD-11: 1D64] | P07711 | CTSL |
| T98691 | DI0376 | Severe acute respiratory syndrome | [ICD-11: 1D65] | P07711 | CTSL |
| T61746 | DI0023 | Alopecia | [ICD-11: ED70] | P07858 | CTSB |
| T61746 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P07858 | CTSB |
| T61746 | DI0037 | Asthma | [ICD-11: CA23] | P07858 | CTSB |
| T61746 | DI0055 | Bone cancer | [ICD-11: 2B5Z] | P07858 | CTSB |
| T61746 | DI0060 | Brain cancer | [ICD-11: 2A00] | P07858 | CTSB |
| T61746 | DI0067 | Cardiac arrest | [ICD-11: MC82] | P07858 | CTSB |
| T61746 | DI0074 | Cerebral ischaemic stroke | [ICD-11: 8B11] | P07858 | CTSB |
| T61746 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P07858 | CTSB |
| T61746 | DI0087 | Chronic pain | [ICD-11: MG30] | P07858 | CTSB |
| T61746 | DI0110 | Cystic fibrosis | [ICD-11: CA25] | P07858 | CTSB |
| T61746 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P07858 | CTSB |
| T61746 | DI0178 | Hepatic fibrosis/cirrhosis | [ICD-11: DB93] | P07858 | CTSB |
| T61746 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P07858 | CTSB |
| T61746 | DI0253 | Meningioma | [ICD-11: 2A01] | P07858 | CTSB |
| T61746 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P07858 | CTSB |
| T61746 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P07858 | CTSB |
| T61746 | DI0296 | Neurodegenerative disorder | [ICD-11: 8A20-8A23] | P07858 | CTSB |
| T61746 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P07858 | CTSB |
| T61746 | DI0351 | Psoriasis | [ICD-11: EA90] | P07858 | CTSB |
| T61746 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P07858 | CTSB |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T05114 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23946 | CMA1 |
| T05114 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P23946 | CMA1 |
| T05114 | DI0169 | Gram-positive bacterial infection | [ICD-11: 1B74-1F40] | P23946 | CMA1 |
| T05114 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P23946 | CMA1 |
| T05114 | DI0229 | Left ventricular failure | [ICD-11: BD11] | P23946 | CMA1 |
| T05114 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | P23946 | CMA1 |
| T76059 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P62942 | FKBP1A |
| T76059 | DI0349 | Pruritus | [ICD-11: EC90] | P62942 | FKBP1A |
| T76059 | DI0413 | Transplant rejection | [ICD-11: NE84] | P62942 | FKBP1A |
| T02001 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q08499 | PDE4D |
| T86057 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q96S37 | SLC22A12 |
| T13127 | DI0342 | Premature ageing appearance | [ICD-11: LD2B] | P49356 | FNTB |
| T43721 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P80365 | HSD11B2 |
| T89988 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P13500 | CCL2 |
| T89988 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P13500 | CCL2 |
| T89988 | DI0087 | Chronic pain | [ICD-11: MG30] | P13500 | CCL2 |
| T89988 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P13500 | CCL2 |
| T89988 | DI0252 | Melanoma | [ICD-11: 2C30] | P13500 | CCL2 |
| T89988 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | P13500 | CCL2 |
| T89988 | DI0275 | Multiple sclerosis | [ICD-11: 8A40] | P13500 | CCL2 |
| T89988 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P13500 | CCL2 |
| T89988 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P13500 | CCL2 |
| T89988 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P13500 | CCL2 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T16016 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P32246 | CCR1 |
| T16016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P32246 | CCR1 |
| T12119 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | Q15858 | SCN9A |
| T12119 | DI0087 | Chronic pain | [ICD-11: MG30] | Q15858 | SCN9A |
| T12119 | DI0140 | Extremities vasodilatation | [ICD-11: EG00] | Q15858 | SCN9A |
| T12119 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q15858 | SCN9A |
| T12119 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | Q15858 | SCN9A |
| T12119 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | Q15858 | SCN9A |
| T12119 | DI0358 | Radiculopathy | [ICD-11: 8B93] | Q15858 | SCN9A |
| T12119 | DI0415 | Trigeminal nerve disorder | [ICD-11: 8B82] | Q15858 | SCN9A |
| T88975 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | Q14432 | PDE3A |
| T88975 | DI0037 | Asthma | [ICD-11: CA23] | Q14432 | PDE3A |
| T88975 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q14432 | PDE3A |
| T88975 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | Q14432 | PDE3A |
| T63414 | DI0224 | Joint pain | [ICD-11: ME82] | Q99572 | P2RX7 |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T12355 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P24385 | CCND1 |
| T41580 | DI0396 | Substance abuse | [ICD-11: 6C40] | P18089 | ADRA2B |
| T26368 | DI0216 | Intentional self-harm | [ICD-11: PC91] | P31644 | GABRA5 |
| T20333 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P07333 | CSF1R |
| T76910 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P49840 | GSK3A |
| T44458 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P50750 | CDK9 |
| T44458 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P50750 | CDK9 |
| T44458 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P50750 | CDK9 |
| T44458 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P50750 | CDK9 |
| T44458 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P50750 | CDK9 |
| T44458 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P50750 | CDK9 |
| T44458 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50750 | CDK9 |
| T24982 | DI0349 | Pruritus | [ICD-11: EC90] | Q12908 | SLC10A2 |
| T45262 | DI0394 | Staphylococcal/streptococcal disease | [ICD-11: 1B5Y] | P34998 | CRHR1 |
| T10822 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P49336 | CDK8 |
| T10822 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P49336 | CDK8 |
| T00176 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q00987 | MDM2 |
| T00176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q00987 | MDM2 |
| T56556 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9UNQ0 | ABCG2 |
| T56556 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UNQ0 | ABCG2 |
| T69485 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43614 | HCRTR2 |
| T73482 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | O43613 | HCRTR1 |
| T73482 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | O43613 | HCRTR1 |
| T73482 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | O43613 | HCRTR1 |
| T92144 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q02763 | TEK |
| T92144 | DI0081 | Chronic arterial occlusive disease | [ICD-11: BD4Z] | Q02763 | TEK |
| T92144 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q02763 | TEK |
| T92144 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | Q02763 | TEK |
| T92144 | DI0365 | Retinopathy | [ICD-11: 9B71] | Q02763 | TEK |
| T92144 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q02763 | TEK |
| T17569 | DI0030 | Angina pectoris | [ICD-11: BA40] | P22460 | KCNA5 |
| T76914 | DI0198 | Idiopathic inflammatory myopathy | [ICD-11: 4A41] | P22001 | KCNA3 |
| T76914 | DI0351 | Psoriasis | [ICD-11: EA90] | P22001 | KCNA3 |
| T76914 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P22001 | KCNA3 |
| T51282 | DI0166 | Glaucoma | [ICD-11: 9C61] | Q13464 | ROCK1 |
| T58470 | DI0363 | Retina cancer | [ICD-11: 2D02] | P20248 | CCNA2 |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T31989 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9NRA0 | SPHK2 |
| T13714 | DI0039 | Atopic eczema | [ICD-11: EA80] | P55055 | NR1H2 |
| T39054 | DI0238 | Lung cancer | [ICD-11: 2C25] | P33316 | DUT |
| T39054 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P33316 | DUT |
| T21123 | DI0019 | Adrenomedullary hyperfunction | [ICD-11: 5A75] | Q99814 | EPAS1 |
| T08910 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P18507 | GABRG2 |
| T08910 | DI0256 | Mental/behavioural/neurodevelopmental disorder | [ICD-11: 6E20-6E8Z] | P18507 | GABRG2 |
| T08910 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P18507 | GABRG2 |
| T84439 | DI0377 | Sex development malformative disorder | [ICD-11: LD2A] | Q6DWJ6 | GPR139 |
| T86385 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P08311 | CTSG |